The α7 nicotinic acetylcholine receptor agonist, A-582941, regulates GSK3β and tau phosphorylation:: Potential for disease modification in Alzheimer's disease

被引：0
|
作者：
Nikkel, A. L. [1 ]
Markosyan, S. [1 ]
Martino, B. [1 ]
Gubbins, E. [1 ]
Li, J. [1 ]
Han, E. K. [1 ]
Luo, Y. [1 ]
Hu, M. [1 ]
Puttfarcken, P. [1 ]
Decker, M. [1 ]
Gopalakrishnan, M. [1 ]
Bitner, R. S. [1 ]
机构：
[1] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA
来源：
BIOCHEMICAL PHARMACOLOGY | 2007年 / 74卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：SMA28 / SMA29
页数：2
相关论文
共 50 条
  • [41] GSK3 and p53-is there a link in Alzheimer's disease?
    Proctor, Carole J.
    Gray, Douglas A.
    MOLECULAR NEURODEGENERATION, 2010, 5
  • [42] GSK3β signalling:: Casting a wide net in Alzheimer's disease
    Bhat, RV
    Budd, SL
    NEUROSIGNALS, 2002, 11 (05) : 251 - 261
  • [43] GSK-3 and Tau: A Key Duet in Alzheimer's Disease
    Sayas, Carmen Laura
    Avila, Jesus
    CELLS, 2021, 10 (04)
  • [44] Association analysis of the partially duplicated α7 nicotinic acetylcholine receptor genetic variant and Alzheimer's disease
    Liou, YJ
    Lai, IC
    Hong, CJ
    Liu, HC
    Liu, TY
    Tsai, SJ
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2001, 12 (05) : 301 - 304
  • [45] Increased alpha 7 nicotinic acetylcholine receptor protein levels in Alzheimer's disease patients.
    Leung-wing, C
    Ma, E
    Lam, K
    Chan, M
    Lee, D
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S42 - S42
  • [46] Modulation of α7 Nicotinic Acetylcholine Receptor and Fibrillar Amyloid-β Interactions in Alzheimer's Disease Brain
    Ni, Ruiqing
    Marutle, Amelia
    Nordberg, Agneta
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 (03) : 841 - 851
  • [47] Neuroprotective and Neurotoxic Implications of α7 Nicotinic Acetylcholine Receptor and Aβ Interaction: Therapeutic Options in Alzheimer's Disease
    Farhat, Syeda Mehpara
    Ahmed, Touqeer
    CURRENT DRUG TARGETS, 2017, 18 (13) : 1537 - 1544
  • [48] Electroacupuncture Protects Cognition by Regulating Tau Phosphorylation and Glucose Metabolism via the AKT/GSK3β Signaling Pathway in Alzheimer's Disease Model Mice
    Xu, Anping
    Zeng, Qingtao
    Tang, Yinshan
    Wang, Xin
    Yuan, Xiaochen
    Zhou, You
    Li, Zhigang
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [49] α7 Nicotinic Acetylcholine Receptor Mediated Neuroprotection in Parkinson's Disease
    Kawamata, Jun
    Suzuki, Syuuichirou
    Shimohama, Shun
    CURRENT DRUG TARGETS, 2012, 13 (05) : 623 - 630
  • [50] α7 Nicotinic Acetylcholine Receptors in Alzheimer's Disease: Neuroprotective, Neurotrophic or Both?
    Hernandez, Caterina M.
    Dineley, Kelly T.
    CURRENT DRUG TARGETS, 2012, 13 (05) : 613 - 622
12345